{"filing":{"accession_number":"0001193125-26-401110","cik":"0001808898","ticker":"BNTC","company_name":"Benitec Biopharma Inc.","form":"8-K","filing_date":"2026-09-24","report_date":"2026-09-18","primary_document":"bntc-20260918.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526401110/bntc-20260918.htm"},"events":[{"id":34936,"run_id":32167,"accession_number":"0001193125-26-401110","anchor_item_number":"4.01","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"The filing discloses a change in the registrant's independent auditor under Item 4.01. Baker Tilly, the auditor since 2020, was dismissed by the Audit Committee on September 18, 2026, and Ernst \u0026 Young LLP was appointed as the successor auditor for the fiscal year ending June 30, 2027. This is a direct and unambiguous auditor change event, material to investors as it affects the firm responsible for attesting to financial statements.","company_name":"Benitec Biopharma Inc.","ticker":"BNTC","filing_date":"2026-09-24","form":"8-K","submitted_at":null,"items":[{"id":38821,"accession_number":"0001193125-26-401110","item_number":"4.01","item_title":"Changes in Registrant’s Certifying Accountant.","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses a change in the registrant's independent auditor under Item 4.01. Baker Tilly, the auditor since 2020, was dismissed by the Audit Committee on September 18, 2026, and Ernst \u0026 Young LLP was appointed as the successor auditor for the fiscal year ending June 30, 2027. This is a direct and unambiguous auditor change event, material to investors as it affects the firm responsible for attesting to financial statements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:39:46.193402+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38821,"accession_number":"0001193125-26-401110","item_number":"4.01","item_title":"Changes in Registrant’s Certifying Accountant.","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses a change in the registrant's independent auditor under Item 4.01. Baker Tilly, the auditor since 2020, was dismissed by the Audit Committee on September 18, 2026, and Ernst \u0026 Young LLP was appointed as the successor auditor for the fiscal year ending June 30, 2027. This is a direct and unambiguous auditor change event, material to investors as it affects the firm responsible for attesting to financial statements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:39:46.193402+00:00","company_name":"Benitec Biopharma Inc.","ticker":"BNTC","filing_date":"2026-09-24"}]}